Magnus Holmer

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Sven Petersson

Karolinska Institutet

SWEDEN

View details

Per Stal

Karolinska Institutet

SWEDEN

View details

Stergios Kechagias

Professor

Linköping University

SWEDEN

View details

Mattias Ekstedt

Linköping University

SWEDEN

View details

Martti Färkkilä

University of Helsinki

FINLAND

View details

Hannes Hagström

Professor, Senior Consultant Hepatologist

Karolinska Institutet

SWEDEN

View details

Stefano Romeo

SWEDEN

View details

Catarina Lindqvist

Karolinska University Hospital

SWEDEN

View details

Ying Shang

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Magnus Holmer

Research Interests

Explore related searches

Contact this professor

Articles (11)

Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study

Risk of major adverse liver outcomes among first‐degree relatives of individuals with MASLD

Associations between dietary fatty acid and plasma fatty acid composition in non-alcoholic fatty liver disease: secondary analysis from a randomised trial with a hypoenergetic low-carbohydrate high-fat and intermittent fasting diet

Macronutrient composition and its effect on body composition changes during weight loss therapy in patients with non-alcoholic fatty liver disease: Secondary analysis of a randomized controlled trial

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up

Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease

Reply to: “Reduced steatosis and weight as a result of specific diets or the dietitian themselves”

Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet – a randomized controlled trial

A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis.

A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis

Etiologies and outcomes of cirrhosis in a large contemporary cohort.

Collaborators (9)

Sven Petersson

Per Stal

Stergios Kechagias

Mattias Ekstedt

Martti Färkkilä

Hannes Hagström

Stefano Romeo

Catarina Lindqvist

Ying Shang

Make your next move.